Market Overview

Eagle Pharmaceuticals, Inc. to Present at 37th Annual J.P. Morgan Healthcare Conference


Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) ("Eagle" or the "Company")
today announced that Scott Tarriff, Chief Executive Officer, and Pete
Meyers, Chief Financial Officer, will present at the 37th Annual J.P.
Morgan Healthcare Conference as follows:

Date:     Wednesday, January 9, 2019
Time: 2:30 p.m. Pacific Standard Time
Location: Westin St. Francis Hotel, San Francisco



The presentation will be webcast live at the aforementioned time, and
archived for 30 days thereafter, via the Company's website at,
under the Investors Section.

About Eagle Pharmaceuticals, Inc.

Eagle is a specialty pharmaceutical company focused on developing and
commercializing injectable products that address the shortcomings, as
identified by physicians, pharmacists and other stakeholders, of
existing commercially successful injectable products. Eagle's strategy
is to utilize the FDA's 505(b)(2) regulatory pathway. Additional
information is available on the Company's website at

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at